Meristemotherapy (Phythoembriotherapy or Gemmotherapy)  is a branch of phytotherapy that uses embryonic plant tissues, such as buds, young shoots, and buds, to promote health and well-being. These tissues, being in the growth phase, are particularly rich in vital substances such as vitamins, minerals, enzymes, and plant hormones, which give them unique therapeutic properties.

Origins and principles of gemmotherapy

In the 1950s, Belgian physician Pol Henry began studying the therapeutic effects of plant embryonic tissue, coining the term "embryonic phytotherapy." The concept was later developed by French physician Max Tétau, who renamed it "gemmotherapy." Gemmotherapy is based on the idea that plant embryonic tissue contains high concentrations of active ingredients, such as auxins, gibberellins, and cytokinins, which can offer therapeutic benefits to humans.

Preparation of gemmoderivatives

Gemmotherapy remedies, known as bud extracts, are prepared by macerating fresh embryonic tissue in a mixture of water, alcohol, and glycerin. This process extracts and preserves the active substances present in young tissue, providing a concentrated version of the plant's beneficial properties.

The preparation of bud extracts follows a specific protocol:

Harvest: The buds and young tissue are harvested in early spring, when they are at their peak development.

Maceration: The fresh plant material is immersed in a glycerin and alcohol solution for three weeks.

Filtration: After maceration, the solution is filtered to obtain the basic glycerin macerate. Dilution: The macerate is diluted in a mixture of glycerin, alcohol, and water to obtain the final product, ready for use.